Attilio appoints Buck Institute CEO Eric Verdin as cochairman
Attilio named Eric Verdin, president and CEO of the Buck Institute for Research on Aging, as cochairman, the company said in a press release. Attilio describes its service as a human powered AI platform focused on longevity.
Verdin will help set the scientific direction for member care, including the use of biomarkers, imaging and clinical protocols. He also designed the Dr. Verdin Baseline Assessment, which Attilio offers to members for $2,500.
Verdin will speak at Attilio's first Longevity Event on October 29 and 30, 2026. The event will take place at Stanford University and the Buck Institute.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind Access Oct 15 UK Medicines Regulator Plans AI Safety Tools by 2030Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Deep Longevity to Launch Accrua Telehealth Platform in US
Humanitas AI Appoints Former Verizon CEO Hans Vestberg as Senior Advisor
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Cadent Names Lisa Utzschneider Interim CEO
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Daily AI Brief: the AI news that matters, in your inbox.